Ansell A/S
Austin, US · 1 known investors
Find your way into Ansell A/S
Sign up to see every warm intro you have to Ansell A/S
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ansell A/S team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ansella Therapeutics develops novel vaginal formulations for women's health conditions using biomimetic materials science and biomedical engineering, focused on treating menopause, vaginal dryness, dyspareunia, vaginal mucositis, endometriosis, uterine fibroids, and vaginal infections.
Investors · 1
Forepont Capital Partnerslisted by Forepont Capital PartnersNew York
How we know: Forepont Capital Partners's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Ansell A/S do?
- Ansella Therapeutics develops novel vaginal formulations for women's health conditions using biomimetic materials science and biomedical engineering, focused on treating menopause, vaginal dryness, dyspareunia, vaginal mucositis, endometriosis, uterine fibroids, and vaginal infections.
- Who are Ansell A/S's investors?
- Ansell A/S's investors include Forepont Capital Partners.
- Where is Ansell A/S headquartered?
- Ansell A/S is headquartered in Austin, US.
